| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 98.33B | 98.26B | 124.86B | 123.90B | 119.32B | 120.00B |
| Gross Profit | 22.91B | 22.66B | 25.31B | 24.18B | 22.51B | 21.47B |
| EBITDA | 8.55B | 8.29B | 10.13B | 7.91B | 7.18B | 5.82B |
| Net Income | 5.04B | 4.76B | 5.48B | 3.52B | 2.80B | 2.35B |
Balance Sheet | ||||||
| Total Assets | 75.55B | 80.06B | 81.07B | 83.21B | 79.23B | 76.20B |
| Cash, Cash Equivalents and Short-Term Investments | 41.30B | 38.71B | 38.70B | 20.88B | 19.16B | 15.94B |
| Total Debt | 9.83B | 9.55B | 10.19B | 10.99B | 12.51B | 12.85B |
| Total Liabilities | 31.57B | 35.43B | 40.20B | 47.82B | 46.03B | 45.03B |
| Stockholders Equity | 43.57B | 44.16B | 40.40B | 34.95B | 32.85B | 30.93B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.13B | 4.01B | 3.17B | 3.69B | -1.44B |
| Operating Cash Flow | 0.00 | 3.41B | 4.95B | 4.26B | 5.56B | 749.00M |
| Investing Cash Flow | 0.00 | -792.00M | 15.47B | 39.00M | -4.00M | -1.27B |
| Financing Cash Flow | 0.00 | -2.60B | -2.61B | -2.61B | -2.41B | -2.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥45.50B | 11.72 | ― | 3.48% | 18.42% | 51.06% | |
74 Outperform | ¥27.94B | 9.19 | ― | 3.66% | -18.88% | 42.17% | |
68 Neutral | ¥58.60B | 11.15 | ― | 2.82% | -5.63% | 52.73% | |
68 Neutral | ¥106.98B | 9.90 | ― | 2.91% | 31.48% | 83.15% | |
66 Neutral | ¥46.60B | 12.65 | ― | 2.70% | 17.96% | 30.46% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
Tsuzuki Denki announced that interim financial results for the second quarter of the fiscal year ending March 31, 2026, at its unlisted parent company ASO CORPORATION, have been finalized, underscoring the close capital and business ties between the two groups. The disclosure highlights ASO’s core operations in medical-related and real estate businesses, its 24.03% voting stake in Tsuzuki Denki, and a shareholder structure dominated by the Aso family and related entities, indicating a tightly held ownership base that may support stable governance and long-term strategic alignment between the parent and its listed affiliate.
The most recent analyst rating on (JP:8157) stock is a Hold with a Yen3364.00 price target. To see the full list of analyst forecasts on Tsuzuki Denki Co., Ltd. stock, see the JP:8157 Stock Forecast page.
Tsuzuki Denki Co., Ltd. announced extraordinary income and losses for the second quarter of the fiscal year ending March 31, 2026. The company gained 990 million yen from selling certain investment securities, aligning with its strategic shareholding policy. Conversely, a loss of 956 million yen was recorded due to a reassessment of its ERP system implementation, opting for a more efficient modification of existing systems. Despite these financial adjustments, the company expects minimal impact on its consolidated results for the fiscal year.
The most recent analyst rating on (JP:8157) stock is a Hold with a Yen3364.00 price target. To see the full list of analyst forecasts on Tsuzuki Denki Co., Ltd. stock, see the JP:8157 Stock Forecast page.
Tsuzuki Denki Co., Ltd. reported a significant improvement in its financial performance for the six months ending September 30, 2025, with net sales increasing by 3.8% and operating profit surging by 78.6% compared to the previous year. This strong performance reflects the company’s robust market positioning and operational efficiency, potentially enhancing stakeholder confidence and reinforcing its competitive standing in the industry.
The most recent analyst rating on (JP:8157) stock is a Hold with a Yen3364.00 price target. To see the full list of analyst forecasts on Tsuzuki Denki Co., Ltd. stock, see the JP:8157 Stock Forecast page.